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ABSTRACT
Deep sequencing of RNAs (RNA-seq) has been
a useful tool to characterize and quantify tran-
scriptomes. However, there are significant chal-
lenges in the analysis of RNA-seq data, such as
how to separate signals from sequencing bias and
how to perform reasonable normalization. Here, we
focus on a fundamental question in RNA-seq
analysis: the distribution of the position-level read
counts. Specifically, we propose a two-parameter
generalized Poisson (GP) model to the position-level
read counts. We show that the GP model fits the
data much better than the traditional Poisson
model. Based on the GP model, we can better
estimate gene or exon expression, perform a more
reasonable normalization across different sam-
ples, and improve the identification of differentially
expressed genes and the identification of differen-
tially spliced exons. The usefulness of the GP model
is demonstrated by applications to multiple RNA-
seq data sets.
INTRODUCTION
With the advance of high-throughput sequencing techno-
logies, transcriptomes can be characterized and quantiﬁed
at an unprecedented resolution. Deep sequencing of
RNAs (RNA-seq) has been successfully applied to many
organisms (1–5). However, there are still many challenges
in analyzing RNA-seq data. In this work, we focus on a
basic question in RNA-seq analysis: the distribution of the
position-level read count (i.e. the number of sequence
reads starting from each position of a gene or an exon).
It is usually assumed that the position-level read
count follows a Poisson distribution with rate  .
The gene length-normalized read count, which is a
popular gene expression estimate, is then the maximum
likelihood estimator (MLE) of  . In addition, Jiang et al.
(6) modeled the read count as a Poisson variable to
estimate isoform expression. However, as we show in
this work, a Poisson distribution with rate   cannot
explain the non-uniform distribution of the reads across
the same gene or the same exon. A different distribution is
in need to better characterize the randomness of the
sequence reads.
We propose using a two-parameter generalized Poisson
(GP) model for the gene and exon expression estimation.
Speciﬁcally, we ﬁt a GP model with parameters   and l to
the position-level read counts across all of the positions of
a gene (or an exon). The estimated parameter   reﬂects the
transcript amount for the gene (or exon) and   represents
the average bias during the sample preparation and
sequencing process. Or the estimated y can be treated as
a shrunk value of the mean with the shrinkage factor l.
We found that the GP model can better estimate gene
(or exon) expression by separating true signals from
sequencing bias.
It has been shown that normalization continues to be a
critical component of RNA-seq analysis (7). A few highly
expressed genes speciﬁc to one sample can make the
library-size based normalization approach inappropriate.
Our proposed GP model shows that for some highly ex-
pressed genes, many of the reads might be caused by
sequencing bias. By removing the sequencing bias
captured by l, we can better perform the normalization
across different samples. It has also been observed that in
differentially expressed gene studies, although the
gene-level read counts across replicate lanes can be ﬁtted
by a Poisson distribution, the ﬁt is inappropriate when
applied to biological replicates or different biological
samples (1). In addition, the parameter estimation for
the biological effect may be unreliable given the small
number of replicate lanes. On the other hand, based on
our GP model, we can better identify differentially ex-
pressed genes and differentially spliced exons through
log-likelihood ratio approaches. These conclusions are
demonstrated by applying our model to multiple
RNA-seq data sets in multiple organisms.
*To whom correspondence should be addressed. Tel: +1 213 740 2143; Fax: +1 213 740 8631; Email: liang.chen@usc.edu
Published online 29 July 2010 Nucleic Acids Research, 2010, Vol. 38, No. 17 e170
doi:10.1093/nar/gkq670
 The Author(s) 2010. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.MATERIALS AND METHODS
Two-parameter generalized Poisson model for
RNA-seq data
For each gene, let X represent the number of mapped
reads starting from an exonic position of the gene. The
observed counts are {x1,...,xn} where n is the total
number of non-redundant exonic positions (or gene
length). The sum of xi’s is equal to the total number of
reads mapped to this gene. We assume that X follows a
GP distribution with parameters   and l:
Pr X ¼ x ðÞ ¼    +xl ðÞ
x 1e   xl=x!,
0
 
x ¼ 0, 1, 2,:::,
for x > q ifl < 0,
where  >0, max( 1,  /q) l 1, and q ( 4) is the
largest positive integer for which  +ql>0 when l<0.
The lower limits on l and q 4 are imposed to ensure
that there are at least ﬁve classes with non-zero pro-
babilities and the truncation errors [i.e.
P1
x¼0 Pr X ¼ x ðÞ
is a little <1] do not affect practical applications. When
l=0, the GP model reduces to the Poisson model. From
our results on the real datasets, more than 99% of the l
estimates were >0. The mean of X is:m= (1 l)
 1, and
the variance of X is: s
2= (1 l)
 3. The GP distribution
was deﬁned and studied by Consul and Jain (8,9).
In RNA-seq experiments, the parameter   can be treated
as the transcript amount for the gene and l represents the
bias during the sample preparation and sequencing
process. The underlying mechanisms for the sequencing
bias remain unknown and need further investigation.
The MLE ^ l of l can be obtained by solving the follow-
ing equation using the Newton–Raphson method:
X n
i¼1
xi 1   xi ðÞ
  x+xi     x ðÞ l
  n  x ¼ 0, where   x ¼
X n
i¼1
xi
n
:
The MLE ^   of   can be obtained from: ^   ¼   xð1   ^ lÞ .
Thus, ^   is a shrunk value of the sample mean if ^ l >0. This
relationship can also be inferred by the equation that
 =m(1 l). Note that there is no MLE if all of the x’s
are equal to 0 or 1. The same model can be speciﬁed for an
exon. The observed read counts at the positions are
{z1,...,zm} and m is the exon length.
Normalization issue
To identify differentially expressed genes, we need
to perform normalization. The total amount of sequenced
RNAs in sample 1 can be estimated by s1 ¼
PG
g¼1 ^  1,glg,
where ^  1,g is the MLE of   in the GP model for gene g
in sample 1, lg is the gene length, and G is the total number
of genes. Similarly, the total amount of sequenced RNAs
in sample 2 can be estimated by s2 ¼
PG
g¼1 ^  2,glg, where
^  2,g is the MLE of   for gene g in sample 2. To perform
normalization, we assume that the total amount of RNAs
in sample 1 is equal to the total amount of RNAs in
sample 2. Therefore, the scaling factor for the comparison
between the two samples can be estimated as:
w ¼
s2
s1
:
when lg=0, ^  g ¼   xg which is the MLE for the Poisson
model. When lg=0 for all g’s, the scaling factor is
the same as that in the normalization procedure using
the total number of mapped reads (here only reads
mapped to the transcriptome were considered). When
lg>0, ^  g <   xg we remove extra reads that are due to the
biased sequencing for this gene. When lg<0, ^  g >   xg we
compensate read counts for this gene because some of
reads cannot be sequenced successfully. In our applica-
tions, we found that the majority of genes had a positive
lg. The ratio of the gene expression between two samples
can be estimated as w^  1,g=^  2,g.
Methods to identify differentially expressed genes
We used the likelihood ratio test to identify differentially
expressed genes. Let X represents the position-level read
count in sample 1. Similarly, Y is the random variable for
the gene in sample 2. To estimate the unrestricted MLEs,
we have:
Pr X ¼ x ðÞ ¼  1  1+xl1 ðÞ
x 1e  1 xl1=x!,
Pr Y ¼ y ðÞ ¼  2  2+yl2 ðÞ
y 1e  2 yl2=y!,
where ( 1,l1) and ( 2,l2) can be estimated by the
maximum likelihood approach mentioned above inde-
pendently. When l1<0o rl2<0 and some x’s or y’s are
larger than the corresponding q values (see the probability
mass function of the GP distribution for the meaning of
q), the likelihood is zero and the parameter estimation
fails. Under the null hypothesis (restricted parameter
space), in which the gene is not differentially expressed,
we have
Pr X ¼ x ðÞ ¼    +xl1 ðÞ
x 1e   xl1=x!,
Pr Y ¼ y ðÞ ¼ w  w +yl2 ðÞ
y 1e w  yl2=y!,
where w is a normalization constant associated with the
different sequencing depths for the two samples. We can
choose w ¼ s2=s1, and s1 and s2 were calculated based on
the unrestricted maximum likelihood model. Through the
parameter speciﬁcation, we preserved the original counts.
l1 and l2 were taken as the same values of the MLEs from
the unrestricted maximum likelihood model. Thus, we
assumed that the MLE of l from the unrestricted
maximum likelihood model was close to the true value.
Then the restricted proﬁle MLE ^   can be obtained
by solving the equation using the Newton–Raphson
method:
2n
 
  n+nw ðÞ +
X n
i¼1
xi   1 ðÞ
 +xi^ l1
+
X n
i¼1
yi   1 ðÞ w
w +yi^ l2
¼ 0:
The log-likelihood ratio test statistic can be calculated as:
T ¼  2ln
L ^  , ^ l1, ^ l2jx,y
  
L ^  1, ^  2, ^ l1, ^ l2jx,y
  
0
@
1
A:
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To perform the comparison, we also used the Poisson
model and the log-likelihood ratio approach to identify
differentially expressed genes. For the unrestricted
Poisson model:
Pr X ¼ x ðÞ ¼
 x
1e  1
x!
and Pr Y ¼ y ðÞ ¼
 
y
2e  2
y!
:
The MLEs are ^  1 ¼   x and ^  2 ¼   y. For the restricted null
model:
Pr X ¼ x ðÞ ¼
 xe  
x!
and Pr Y ¼ y ðÞ ¼
w  ðÞ
ye w 
y!
,
where w can be chosen as
PG
g¼1   yglg=
PG
g¼1   xglg. The
proﬁle MLE under the null is
^   ¼
Pn
i¼1 xi+
Pn
i¼1 yi
n+nw
:
The log-likelihood ratio test statistic can be calculated as:
T ¼  2ln
L ^  jx,y
  
L ^  1, ^  2jx,y
  
0
@
1
A,
and it follows a chi-square distribution with one degree of
freedom if the null model is true.
We also used the generalized linear model
(GLM) proposed in ref. (1) for the ROC curve study.
The log/Poisson link function was used for the linear
model:
log ER i,jjdi
     
¼ logdi+ ai ðÞ ,j+ i,j,
where Ri,j is the number of reads mapped to gene j in lane
i, ta(i),j is the biological effect for gene j in the biological
group a(i), di,j is other technical effect (i.e. ﬂow cell effect),
di is the total number of uniquely mapped reads for lane
i and the regression coefﬁcient of logdi is set to 1. For
the MAQC-2 data, there are two biological groups:
UHR and brain samples distributed among 14 lanes.
Therefore i ranges from 1 to 14. a(i)=1(UHR) for the
ﬁrst seven lanes, and a(i)=0 (brain) for the last seven
lanes. These 14 lanes were distributed among two ﬂow
cells so that d=(1,0,1,0,1,0,1,0,1,0,1,0,1,0). The log-
likelihood ratio statistic was calculated based on the full
and the null model in which the biological effect is zero.
Besides the log/Poisson link function, we also applied the
negative binomial and the quasi-Poisson link functions
in the GLM.
Methods to identify differentially spliced exons
For the differentially spliced exon study, we focused on
‘skipped exon’ events without considering other alterna-
tive splicing events such as alternative 50 splice sites or
alternative 30 splice sites. In sample 1, the read count for
the considered middle exon is Z, and the read count for
the corresponding gene is X. In sample 2, the variable
for the exon is V, and the variable for the gene is Y.
Under the unrestricted parameter space, we can estimate
the related parameters for Z, X, V and Y using the method
mentioned before. The resultant estimators are: ^  Z, ^ lZ, ^  X,
^ lX, ^  V, ^ lV, ^  Y, ^ lY . Under the restricted null model, in
which the exon is not differentially skipped or the
splicing ratio between the exon expression and the gene
expression (b) is the same between the two samples, we
have:
Pr Z ¼ z ðÞ ¼
b 1 b 1+zl1 ðÞ
z 1e b 1 zl1
z!
,
Pr X ¼ x ðÞ ¼
 1  1+xl2 ðÞ
x 1e  1 xl2
x!
,
Pr V ¼ v ðÞ ¼
b 2 b 2+vl3 ðÞ
v 1e b 2 vl3
v!
,
Pr Y ¼ y ðÞ ¼
 2  2+yl4 ðÞ
y 1e  2 yl4
y!
,
where b>0. The l1, l2, l3 and l4 were taken as ^ lZ, ^ lX, ^ lV
and ^ lY, respectively. The proﬁle MLEs of  1,  2 and b can
be obtained by solving:
m+n
 1
+
X m
i¼1
zi   1 ðÞ
b
b 1+zi^ lZ
+
X n
i¼1
xi   1 ðÞ
1
 1+xi^ lX
  mb+n ðÞ ¼ 0,
m+n
 2
+
X m
i¼1
vi   1 ðÞ
b
b 2+vi^ lV
+
X n
i¼1
yi   1 ðÞ
1
 2+yi^ lY
  mb+n ðÞ ¼ 0,
X m
i¼1
zi   1 ðÞ
 1
b 1+zi^ lZ
+
X m
i¼1
vi   1 ðÞ
 2
b 2+vi^ lV
  m  1+ 2 ðÞ +
2m
b
¼ 0:
The log-likelihood ratio test-statistic can be calculated as:
T ¼  2ln
L ^ b, ^  1, ^  2, ^ lZ, ^ lX, ^ lV, ^ lYjz,x,v,y
  
L ^  Z, ^ lZ, ^  X, ^ lX, ^  V, ^ lV, ^  Y, ^ lYjz,x,v,y
  
0
@
1
A:
It follows a chi-square distribution with the degree of free-
dom=1 if the null model is true.
For the Poisson model, the MLEs of the Poisson par-
ameters are those sample means: ^  Z ¼   z, ^  X ¼   x, ^  V ¼   v,
^  Y ¼   y . Under the null model:
Pr Z ¼ z ðÞ ¼
b 1 ðÞ
ze b 1
z!
, Pr X ¼ x ðÞ ¼
 x
1e  1
x!
,
Pr V ¼ v ðÞ ¼
b 2 ðÞ
ve b 2
v!
, Pr Y ¼ y ðÞ ¼
 
y
2e  2
y!
:
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^  1 ¼
Pm
i¼1 zi+
Pn
i¼1 xi
n+mb
, ^  2 ¼
Pm
i¼1 vi+
Pn
i¼1 yi
n+mb
,
^ b ¼
n
Pm
i¼1 zi+
Pm
i¼1 vi
  
m
Pn
i¼1 xi+
Pn
i¼1 yi
   :
T ¼  2lnðLð ^ b, ^  1, ^  2jz,x,v,yÞ=Lð^  Z, ^  X, ^  V, ^  Yjz,x,v,yÞÞ
follows a chi-square distribution with one degree of
freedom if the null model is true.
Simulation strategy to calculate P-values
In the likelihood ratio tests to identify differentially ex-
pressed genes or differentially spliced exons, we treated
the l estimates from the unrestricted model as true
values and put them into the proﬁle likelihood calculation
for simplicity. The derived test statistics T may not exactly
follow a chi-square distribution with one degree of
freedom under the null. To better estimate the P-values,
we adopted a simulation strategy. For each nucleotide
position, we randomly assigned the mapped reads to the
two considered conditions. The simulated sample pair
should have no differentially expressed genes or differen-
tially spliced exons. We repeated the simulations 1000
times. For each simulated sample pair i, we calculated
the test statistics Tgi for each gene g. The distribution of
Tgi’s (I=1,...,1000) is the null distribution of the test
statistic for gene g. To obtain an accurate P-value for
the observed test statistic, we ﬁtted the distribution
of Tgi’s by a Gamma distribution and calculated the
P-value based on the Gamma distribution. Remember
that if Q follows a chi-square distribution with degrees
of freedom u and c is a positive constant, then c Q
follows a gamma distribution with parameter u/2 and 2c.
In our considered datasets, the null distribution can be
well ﬁtted by a Gamma distribution for more than 84%
of genes (the P-value based on the Kolmogorov–Smirnov
test >0.05).
Real data sets
The real data sets we used included: (i) The MAQC data
including the MAQC-2 and the MAQC-3 data from
ref. (1). The MAQC-2 data were for two biological
samples (human UHR and brain samples) and each
sample had seven lanes distributed across two ﬂow-cells.
The MAQC-3 data were for the UHR sample with four
different library preparations. (ii) The human data were
for nine human tissues and ﬁve breast cancer cell lines (5).
(iii) The mouse data were for three mouse tissues, each
with two replicates (3). The controlled hydrolysis of
RNA samples was performed before cDNA synthesis.
(iv) The yeast data were for oligo(dT)-primed and
random-hexamer-primed cDNA samples, each with
original, biological and technical replicates (4). All of
these data were obtained from the Illumina sequencing
platforms. These samples had multiple lanes distributed
in one ﬂow-cell or across multiple ﬂow-cells.
For the mouse data, the uniquely mapped reads
including body reads and junction reads were downloaded
from http://woldlab.caltech.edu/rnaseq/. Other data were
downloaded from the Sequence Read Archive http://www
.ncbi.nlm.nih.gov/sra/ as the .fastq ﬁles: SRA010153
for the MAQC data, SRP000727 for the human data
(the two low-coverage MAQC samples were excluded),
SRX000559-SRX000564 for the yeast data. The
sequence reads were mapped to the human genome
(NCBI 37.1 or hg19, downloaded from the NCBI
website) or the yeast genome (downloaded from the
Saccharomyces Genome Database http://www
.yeastgenome.org/). The unmapped reads were further
mapped against the human refseq RNA sequences (down-
loaded from the NCBI website) or the yeast ORF se-
quences (downloaded from the Saccharomyces Genome
Database). The resultant reads were treated as junction
reads. Note that we only used the uniquely mapped
reads and removed the multi-reads. The mapping was per-
formed by using Bowtie, version 0.12.1 and the default
settings (10). The Refseq gene annotations for human
and mouse were downloaded from the NCBI website
and the ORF gene annotations for yeast were downloaded
from the Saccharomyces Genome Database. We only con-
sidered genes on autosomes or X chromosomes. The
position-level read count was the number of body or
junction reads starting from an exonic position of a gene
(or an exon) without considering the strand information
because the sample preparation did not consider strands.
A non-redundant exon list was assembled from the Refseq
gene annotations or the ORF gene annotations. If two
exons were overlapped, they were broken into three
‘exons’: the region speciﬁc to exon 1, the shared region,
and the region speciﬁc to exon 2. Note that both alterna-
tive exons and constitutive exons were included.
To demonstrate that ^   of the GP model can better rep-
resent gene expression levels, we utilized the QuantiGene
data for the MAQC-2 samples (11). The QuantiGene
system detects RNA directly without reverse transcrip-
tion and PCR ampliﬁcation. The background-corrected
signals were averaged across the replicates with detectable
expression. If more than two-thirds of the replicates
had detectable expression, the gene was included in the
regression analysis in Table 2. For each regression,
we further required that the gene had an available expres-
sion estimate from the considered statistical model. The
sample size for these regression models was around 170.
To validate our differentially expressed genes, we also
utilized the quantitative real-time PCR (qRT-PCR) data
for the MAQC-2 samples (12). The DCt values with
respect to POLR2A (endogenous control gene) were
averaged across the replicates with detectable expression.
If  75% of the replicates had detectable expression for
both samples, the gene was claimed to have a reliable
log-ratio value in the qRT-PCR data set. To validate
our identiﬁed differentially spliced exons, we used an
enlarged junction list downloaded from http://genes.mit.
edu/burgelab/mRNA-Seq/ which included a large number
of known and predicted junctions. The liftOver tool from
the UCSC genome browser was used to convert the co-
ordinates of the junctions between version hg18 and hg19.
We remapped the reads to the enlarged junction lists using
BLAST (13), requiring at most two mismatches and at
least four matched bases on each side of the junction.
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sion rate of a middle exon. The inclusive junction reads
were those starting at the 30 end of the exon (50 splice site)
and those ending at the 50 end of the exon (30 splice site).
The exclusive junction reads were those skipping the con-
sidered middle exon.
Computation efﬁciency and software package
The codes for the GP model were written in C and the
program was computationally efﬁcient. For example, for
the MAQC data with a total of six samples, starting from
the position-level read counts, it took  1min to estimate
the gene and exon expression, 2min to identify differen-
tially expressed genes, and 5min to identify differentially
spliced exons. The memory used was  800 Mb on a single
CPU and the memory can be further decreased if the six
samples were run separately. But it took more time if we
used the simulation strategy to calculate the P-values
for the identiﬁcation of differentially expressed genes
and differentially spliced exons. We also prepared an
R-package ‘GPseq’ to implement the methods proposed
here. These can be downloaded at: http://www-rcf.usc
.edu/ liangche/software.html.
RESULTS
Gene and exon expression estimation
We ﬁtted a GP model to the position-level counts of a
gene or an exon. The parameters   and l were estimated
using the maximum likelihood approach. We ﬁrst
examined the lane and ﬂow-cell effect on the bias param-
eter l using the MAQC-2 data from ref. (1). In the
MAQC-2 data, each of the two biological samples
(UHR and brain) was sequenced in seven lanes distributed
across two ﬂow-cells. We estimated lg (g=1,...,G; G is
the total number of genes) for each lane separately (the
goodness-of-ﬁt will be further discussed in Table 1). The
correlation of the l values between the seven lanes for the
same sample was around 0.96–0.98. Because the seven
lanes were distributed across two ﬂow-cells, the high cor-
relations also indicated that the ﬂow-cell effect on l was
negligible. The l values were plotted in Supplementary
Figure S1 to further show that they were similar across
replicate lanes. However, the correlation between the
lanes for different biological samples was only around
0.61–0.63, which indicated that the sequencing bias was
biological sample dependent. Note that if two independent
variables X and Y follow the GP distribution with param-
eters ( 1, l) and ( 2, l), the sum of X and Y is also a GP
variable with parameters ( 1+ 2, l) (14). This justiﬁes the
pooling of read counts across lanes that are believed to
have similar sequencing bias. We therefore pooled the
read counts across lanes for the same sample in the fol-
lowing studies. In addition, we should notice that the l
estimate was not robust if a small number of lanes were
used for genes with low expression levels (Supplementary
Figure S2). We further examined the library preparation
effect on the sequencing bias l. In the MAQC-3 data (1),
four different library preparations were used for the UHR
sample. The correlation of the l values between the library
preparations was around 0.97–0.98, indicating that the
library preparation effect was also negligible. In the
yeast data, cDNAs were prepared by either random
hexamers or oligo(dT) primers. The correlation of the ls
between the two library preparations was 0.92.
The goodness-of-ﬁt of the GP model was examined by
the chi-square test. If the P-value for the chi-square
test-statistic was >0.05, we declared that the model ﬁtted
the data well. Table 1 lists the percentages of genes
(or exons) with the position-level count data ﬁtted well
by the GP model or by the Poisson model. The
position-level counts can be ﬁtted well by the GP model
for the majority of genes or exons (77–93%). However, the
Poisson model only ﬁtted well for 2–42% of the genes or
exons. The P-values of the genes that were declared to be
well ﬁtted by the GP model were uniformly distributed
between 0.05 and 1 (Supplementary Figure S3A). The uni-
formity was slightly worse for exons, but still much better
than that of the Poisson model (Supplementary Figure
S3B). For the genes or exons that cannot be ﬁtted by
the GP model, 93–99% of them cannot be ﬁtted by the
Poisson model either, and the ﬁt of the Poisson model was
even worse than the ﬁt of the GP model. The expression
levels of the un-ﬁtted genes and exons were generally
higher than those ﬁtted well by the GP model
(Supplementary Figure S4). It indicated that there was
additional bias not captured by l for the highly-expressed
genes.
Based on the deﬁnition of the GP distribution,
the expectation is:m= (1 l)
 1 and the variance is:
s
2= (1 l)
 3. The parameter l is a measure of the de-
parture from Poissonicity. The variance of the GP distri-
bution is greater than, equal to or less than the expectation
according to whether l>0, l=0 or l<0, respectively.
Consul (14) stated that the parameter   is the average
rate for the natural Poisson process. The parameter l is
Table 1. The percentages of genes and exons with the position-level
count data ﬁtted well by the GP model or the Poisson model
Gene level Exon level
GP (%) Poisson (%) GP (%) Poisson (%)
MAQC data 85.72 1.57 89.62 19.71
Human data 77.28 3.22 88.78 28.35
Mouse data 88.57 7.88 91.73 39.67
Yeast data 93.24 20.49 93.21 23.73
MAQC-2_sep 92.93 10.18 92.90 41.51
If the P-value for the chi-square test >0.05, we declared that the model
ﬁtted the data well. The MAQC data contained both the MAQC-2 and
the MAQC-3 data. The MAQC-2 data were for two biological samples
(human UHR and brain samples). The MAQC-3 data were for
the UHR sample with four different library preparations. The human
data were for nine human tissues and ﬁve breast cancer cell lines.
The mouse data were for three mouse tissues, each with two replicates.
The yeast data were for oligo (dT)-primed and random-
hexamer-primed cDNA samples, each with original, biological and
technical replicates. Note that the majority of yeast genes were
annotated based on ORFs and only a few of genes had introns. The
reads from multiple replicate lanes were pooled together. But for the
MAQC-2_sep data, reads from the seven replicate lanes for each of
the MAQC-2 samples were ﬁtted separately.
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to deviate from the process. A positive value of l indicates
that the subjects are making an effort to accelerate the
natural process and a negative value of l denotes an
effort to retard the process. The GP distribution can
also be interpreted through the quasi-binomial distribu-
tion. Considering a random variable X following a
quasi-binomial distribution I (QBD-I):
Pr X ¼ x ðÞ ¼ m
x
  
pp +x’ ðÞ
x 1 1 p x’ ðÞ
m x:
The X represents the number of successes in m trials.
The probability of success in any one trial is p and in all
other trials is p+xj. The probability of success increases
or decreases depending on the positive or negative j value.
And the change of the probability is proportional to the
number of successes. When m!1, p!0, and j!0
such that mp=  and mj=l, the QBD-I approaches
the GP model with parameter ( ,l) (15). For the
RNA-seq data, the actual transcript amount can be
approximated by a Poisson distribution with parameter
 . The bias introduced in the sample preparation and
sequencing process is represented by l. Therefore, the
observed position-level read count follows the GP distri-
bution with parameters ( , l). Many other models can lead
to the GP distribution. For example, under certain limits,
the generalized negative binomial distribution and the
generalized Markov–Po ´ lya distribution approaches the
GP distribution (14). The GP model has been applied
to many biological problems such as the frequency of
chemically induced chromosome aberrations in human
leukocytes (16).
Furthermore, we used the QuantiGene arrays as gold
standards to show that   can better represent the ‘true
signal’ for gene expression. The QuantiGene system
detects RNA directly without reverse transcription and
PCR ampliﬁcation. The bias introduced in the reverse
transcription and the PCR ampliﬁcation steps can be
avoided. Therefore, the QuantiGene system provides an
accurate gene expression measurement. The QuantiGene
data were obtained from ref. (11). A linear regression
model was ﬁtted between the log of the QuantiGene
signal and the log of the estimated   value. The slope
was 0.94 and 0.90 for the two MAQC-2 samples
(Table 2). However, the slope was 0.72 and 0.71 if the
Poisson estimate was used. The R-square values were
similar for the regression models. A slope different
from 1.0 indicates the compression or expansion effects
between the estimated expression levels and the gold
standard signals. If a slope is equal to 1.0, the
estimated fold change between two different genes of
the same sample is equal to the gold-standard fold
change. As we can see, the slope was closer to 1.0 for
the GP   estimates than the Poisson estimates. It indi-
cates that   can better represent the ‘true signal’ and it
makes the direct comparison between two different genes
reliable.
It has been observed that a few highly expressed genes
contributed a large fraction of sequence reads in certain
tissue samples (17). Figure 1 shows the fraction of mRNA
sample contributed by the highly expressed genes in the
human tissues. The mRNA amount derived from a gene
was equal to the product of the estimated gene expression
multiplied by the gene length:   xglg for the Poisson model,
and ^  glg for the GP model. According to the Poisson
model, the top 10 genes contributed to  15–31% of the
total mRNAs in the human heart, muscle and liver tissues
(Figure 1A). If we used the GP model, the fraction
contributed by highly expressed genes was smaller
(Figure 1B). We examined the top four genes with the
largest contributions to the total RNAs in the liver
tissue based on the Poisson model. The four genes were
also the top genes based on the GP model (ranks 8, 1,
12 and 3). Figure 2 shows the observed frequency of the
read count equal to k (k=0,1,2,...) (blue bars) and the
expected frequencies based on the GP model (magenta
bars) or the Poisson model (brown bars). We only
plotted the ‘k’ values with at least one frequency among
the three types of frequencies  5 for visual convenience.
However, all of the k’s had been used in the parameter
estimation. The GP model ﬁtted much better than the
Poisson model. Note that for these genes, there were
 1.4–3.8% of positions with thousands of reads starting
exactly from these positions (i.e. k 1000). For each of
these ‘k’ values, the frequency of positions with exactly k
number of reads was small (<5) so that they were not
plotted in Figure 2. However, these outliers greatly
affected the MLE of the Poisson model, which resulted
in a peak at a high ‘k’ value for the expected frequencies
(peak of the brown bars), but the observed frequencies
Table 2. Assessment of gene expression estimation based on the QuantiGene gold standards
  estimate from the GP model Mean estimate from the Poisson model
Regression line R
2 Regression line R
2
UHR sample log(y)=4.20+0.94 log(x) 0.62 log(y)=3.38+0.72 log(x) 0.68
Brain sample log(y)=3.92+0.90 log(x) 0.54 log(y)=3.23+0.71 log(x) 0.57
The QuantiGene system detects RNA directly without reverse transcription and PCR ampliﬁcation. The bias introduced in the reverse transcription
and the PCR ampliﬁcation steps is therefore avoided. Y represents the averaged detectable signal from the replicates of the QuantiGene data.
X represents the   estimate from the GP model or the mean estimate from the Poisson model. A slope of 1.0 for the regression line indicates that the
estimated gene expression is accurate and the estimated fold change between two different genes is the same as that from the QuantiGene data. Thus,
log(y1/y2)=1.0 log(x1/x2). The slopes for the   estimates from the GP model were closer to 1.0 compared with those for the mean estimates
from the Poisson model.
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outliers on the GP model was relatively smaller, they still
caused the P-values of the chi-square tests to be <0.05. It
was unrealistic to assume that these outlier reads reﬂected
the gene expression correctly because the majority of the
gene positions did not exhibit such high read counts. It
was more likely that these reads contained sequencing
bias. Therefore, if we counted all the reads mapped to
the gene to estimate the gene expression, we counted
extra reads due to sequencing bias. On the other hand,
the GP model can better separate the bias from the true
signal. The frequencies of the k values beyond the range of
Figure 2 were plotted in Supplementary Figure S5. Note
that all the frequencies were <5 and the GP model still
ﬁtted better than the Poisson model. These highly ex-
pressed genes would affect the normalization across dif-
ferent samples if we used the Poisson estimates, as argued
in ref. (7). We will further discuss about it in the
‘Normalization’ section.
Factors associated with bias k
As we mentioned above, the bias parameter l was inde-
pendent of lanes, ﬂow-cells, and library preparations,
but dependent on biological samples. We further
explored possible factors related to l. We ﬁrst considered
the average number of reads mapped to a gene (  xg).
Although the MLE of l does not have a closed-form ex-
pression, the method of moments estimator of l is:
~ lg¼1 
ﬃﬃﬃﬃﬃﬃﬃﬃ
  xg=s2
g
p
, where s2
g is the sample variance. Therefore
we expect a negative correlation between ^ lg and
ﬃﬃﬃﬃﬃﬃﬃﬃ
  xg=s2
g
p
.
In our real datasets, we found a negative correlation
between
ﬃﬃﬃﬃﬃﬃﬃﬃ
  xg=s2
g
p
and
ﬃﬃﬃﬃ
  xg
p
, the correlation was from around
 0.61 to  0.87. Thus, the increase of the variance was
faster than the increase of the mean. We therefore
expect a positive correlation between ^ lg and
ﬃﬃﬃﬃ
  xg
p
.
Speciﬁcally, the Pearson correlation between ^ lg and
ﬃﬃﬃﬃ
  xg
p
was around 0.66–0.84 for the human tissue and cell line
data, 0.83–0.85 for the yeast data and 0.54–0.75 for the
mouse tissue data. To remove the possible effect of
different robustness of ^ l’s for different genes, we focused
on genes with converged ^ lg from the MAQC-2 data. We
pooled the reads from the seven lanes gradually by adding
one lane each time. Once we added one lane, ^ lg was
calculated again. If ^ lg from the ﬁrst six lanes was within
±5% of the ﬁnal ^ lg from the total seven lanes, the gene
was said to have a converged ^ lg. The correlation between
^ lg and
ﬃﬃﬃﬃﬃ
  xg
p
for these genes was 0.78 for the UHR sample
and 0.81 for the brain sample. Because the increase of the
sample variance was faster than the increase of the sample
mean, there was also a negative correlation between
ﬃﬃﬃﬃﬃﬃﬃﬃ
  xg=s2
g
p
and sg (the correlation was from around  0.19 to  0.71
for the real datasets). This indicates a positive correlation
between sg and ^ lg. Speciﬁcally, we found that the Pearson
correlation between ^ lg and sg was around 0.22–0.71 for all
the considered datasets. The results about   xg and sg also
explained why l was dependent on biological samples
because the expression levels were different.
We next studied the nucleotide composition of each
gene. We counted the occurrence of every possible oligo-
nucleotide with length  6. Because the library prepar-
ations did not consider the strand information, we
pooled the oligonucleotides with their reverse complemen-
tary counterparts. Table 3 lists the top 10 oligonucleotides
with the largest absolute correlations with ^ lg. The mean
value of ^ lg was used if there were multiple biological
samples. For the human tissue and yeast data (oligo(dT)
primed or random-hexamer primed), if a gene was A/T
enriched, the bias parameter l generally tended to be
smaller. However, the pattern was different for the
mouse data in which the hydrolysis of RNA was used
before cDNA priming. It has been shown that the
controlled RNA hydrolysis step signiﬁcantly improves
the uniformity of sequence coverage (3). The nature
of the bias l could be different for the mouse data.
In summary, the bias parameter l is a combined effect
of the expression level, nucleotide composition and experi-
mental procedures such as RNA hydrolysis before cDNA
reverse transcription.
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To perform the normalization across different samples,
the total RNA amount was always assumed to be equal.
Denote the total RNA amount for the kth sample as
sk ¼
PG
g¼1 ^  k,glg, where ^  k,g is the estimated expression
level of gene g in sample k, and lg is the gene length. To
compare sample 1 with 2, the expression level in sample 2
can be adjusted by multiplying s1/s2. If we assume that the
position-level count across different positions of the gene
follows a Poisson distribution, the MLE ^  k,g is the
average number of reads mapped to gene   xk,g
  
, and
then sk is the total number of reads mapped to the tran-
scriptome. Thus, this is the standard normalization to the
total number of reads. If we assume that the position-
level count follows a two-parameter GP distribution,
^  k,g ¼ ^  k,g. We remove the reads due to sequencing bias
when we calculate the total RNA amount. Robinson and
Oshlack argued that some highly expressed genes speciﬁc
to one sample will lead to more falsely declared differen-
tially expressed genes if the standard normalization is
applied (7). They proposed a weighted trimmed mean
approach to remove extreme values when calculate the
normalization factor. Our MLE ^   for the GP model is
equal to   xð1   ^ lÞ. It can be treated as a shrunk value of
  x, which trims the extreme RNA amount contributed by a
single gene in nature. We should note that more than 99%
of the ^ l’s in our applications were >0. In addition, we
have  =m(1 l). Therefore 1 l represents how muchm
needs to shrink to approach the true gene expression
rate  . Therefore, we treated   as the parameter represent-
ing gene expression and l as the shrinkage parameter. As
shown in Figure 1, the GP expression estimates of highly
expressed genes were shrunk toward smaller values.
Therefore the effect of a few outlier genes on the normal-
ization factor was relatively small.
Identiﬁcation of differentially expressed genes
Based on the GP model, the log-likelihood ratio
approaches were proposed to identify differentially
expressed genes. The scaling normalization factor (s2/s1)
was used directly in the parameter estimation, while the
data itself were not modiﬁed and the sampling properties
were preserved. To evaluate our model, we used the tech-
nical or biological replicates. There should be no differen-
tially expressed genes between technical replicates if the
sequencing depth is similar. If the sequencing depth is
unbalanced, certain genes are detected in one sample but
they are not detected or poorly detected in the other
sample, which will still lead to ‘differentially expressed
genes’. Table 4 lists the number of differentially expressed
genes declared from the comparison of these replicates.
The false discovery rate was controlled at 0.0001. In
general, the GP model declared less differentially ex-
pressed genes. For the MAQC-3 data, they were technical
replicates of the UHR sample with different library prep-
arations, and the sequencing depth was comparable
between the replicates. The GP model identiﬁed no differ-
entially expressed genes. However, the Poisson model still
identiﬁed as many as 120 differentially expressed genes,
which can be treated as false positives. For the mouse
data, the sequencing depth was much deeper for the
second replicates. Although we performed normalization,
both models identiﬁed many false positives (left panel).
If we randomly selected a subset of the uniquely mapped
reads from the original larger sample to make the
sequencing depth equal, the GP model identiﬁed much
less false positives (right panel). However, the Poisson
model still identiﬁed as many as 1007 false positives.
The results indicated that we should design the same
number lanes for the two-sample comparison to keep
the sequencing depth similar. The results also indicated
the need for a more complicated normalization method
for two samples with very different sequencing depth
(e.g. the ratio of sequencing depth = 0.55). For the tech-
nical replicates of the yeast data, although the sequencing
depth was very different, the GP model identiﬁed no false
positives while the Poisson model identiﬁed a few false
positives. The difference between biological replicates
was larger than the difference between technical replicates,
Table 3. Top 10 oligonucleotides with the largest absolute correlations with ^  
Human tissue Yeast_random_hexamer Yeast_oligo(dT) Mouse tissue
Motif Corr Motif Corr Motif Corr Motif Corr
ACT or AGT  0.312 ATA or TAT  0.550 ATA or TAT  0.543 AG or CT  0.350
Ao rT  0.311 ATAA or TTAT  0.507 ATAA or TTAT  0.495 AGAG or CTCT  0.349
TA  0.310 AATA or TATT  0.495 AATA or TATT  0.488 CAG or CTG  0.347
TTTC or GAAA  0.308 TAAA or TTTA  0.495 TAAA or TTTA  0.484 CTC or GAG  0.346
ATTC or GAAT  0.308 AT  0.486 AT  0.474 TC or GA  0.342
TCA or TGA  0.308 AAAA or TTTT  0.481 AAAA or TTTT  0.469 TCTG or CAGA  0.342
TAG or CTA  0.308 ATG or CAT  0.478 AAAT or ATTT  0.462 AGC or GCT  0.341
AT  0.307 AAAT or ATTT  0.473 ATG or CAT  0.462 C or G  0.340
TTCA or TGAA  0.306 ATTA or TAAT  0.471 ATTA or TAAT  0.458 TCC or GGA  0.339
ACA or TGT  0.306 TA  0.468 TA  0.458 AGA or TCT  0.339
Every possible oligonucleotide with length  6 was considered. The occurrences of the oligonucleotides and their reverse complementary counterparts
were pooled together for each gene. The correlation between the log of the oligonucleotide frequency and ^   was calculated and ranked based on the
absolute value. For the human tissue data, the average ^   across the nine tissues was used. For the yeast data, the samples were prepared using
random hexamer or oligo(dT) primers. For the mouse data, the average ^   across three tissues were used. The hydrolysis of RNA was performed
before cDNA priming for the mouse data.
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above analysis, we obtained the P-values for the likelihood
ratio tests based on the chi-square distribution with one
degree of freedom. We also calculated the P-values based
on the simulation strategy mentioned in ‘Materials and
Methods’ section. The results are listed in
Supplementary Table S1. The GP model still identiﬁed
less number of differentially expressed genes between tech-
nical replicates with similar sequencing depth, compared
with the Poisson model.
To further validate our methods, we utilized the
real-time PCR (qRT-PCR) data for the MAQC UHR
and brain samples (12). Genes with qRT-PCR absolute
log-ratio <0.2 were treated as negatives and genes with
qRT-PCR absolute log-ratio >2.0 were treated as posi-
tives. The same criteria were used in ref. (1). Then the
log-likelihood ratio tests based on the GP model and the
Poisson model were performed for these gold-standard
genes, respectively. In addition, we considered the GLM
proposed in ref. (1) with the log/Poisson link function, the
negative binomial link function, and the quasi-Poisson
link function. In the GLM, the replicate lanes were con-
sidered separately. The true positive rate and the false
positive rate were calculated for each given threshold on
the test statistics. Figure 3 shows the ROC curves. It
clearly shows that the GP model performs better than
the Poisson and the generalized linear models. The ROC
curves ignored the genes with absolute log-ratio between
0.2 and 2.0 (‘no-call’ genes). Ideally, these ‘no-call’ genes
should have the P-values between the P-values for the
Table 4. The number of differentially expressed genes declared from the comparison of technical or biological replicates
Original data
GP Poisson GP Poisson
MAQC-3: library 1 versus library 2 (1.11) 0 47 MAQC-3: library 1 versus library 3 (0.98) 0 6
MAQC-3: library 1 versus library 4 (1.02) 0 120 MAQC-3: library 2 versus library 3 (0.89) 0 43
MAQC-3: library 2 versus library 4 (0.92) 0 7 MAQC-3: library 3 versus library 4 (1.04) 0 118
Original data Random subset from the original data
GP Poisson GP Poisson
Mouse_brain: original versus technical
replicates (0.55)
422 390 Mouse_brain: original versus technical replicates (1.0) 2 265
Mouse_liver: original versus technical
replicates (0.75)
67 823 Mouse_liver: original versus technical replicates (1.0) 27 720
Mouse_muscle: original versus technical
replicates (0.86)
171 1085 Mouse_muscle: original versus technical replicates (1.0) 119 1007
Yeast_ random_hexamers: original versus
technical replicates (0.66)
0 8 Yeast_ random_hexamers: original versus technical replicates (1.0) 0 8
Yeast_ oligo_dT: original versus technical
replicates (0.64)
0 2 Yeast_ oligo_dT: original versus technical replicates (1.0) 0 1
Yeast_ random_hexamers: original versus
biological replicates (0.96)
280 590 Yeast_ random_hexamers: original versus biological replicates (1.0) 275 579
Yeast_ oligo_dT: original versus biological
replicates (1.38)
203 571 Yeast_ oligo_dT: original versus biological replicates (1.0) 163 487
The numbers in the brackets were the sequencing depth ratio between the two samples. The sequencing depth was deﬁned as the total number of
reads that can be uniquely mapped to the genome or junctions. For the mouse and yeast data, besides the studies on the original data sets, we also
randomly selected a subset of the uniquely mapped reads from the original larger sample so that the sequencing depth was the same for these two
samples. The false discovery rate was controlled at 0.0001. Only genes with existing MLEs of the parameters for both the GP and the Poisson models
in the two samples were considered.
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Figure 3. ROC curves for the GP, the Poisson and the GLM (Poisson,
negative binomial and quasi-Poisson links) in the identiﬁcation of dif-
ferentially expressed genes. Genes with the estimates in the six models
and a reliable log-ratio value in the qRT-PCR experiments were con-
sidered. We further limited our studies on the standard positives
(qRT-PCR absolute log-ratio >2.0, n=218) and the standard nega-
tives (qRT-PCR absolute log-ratio <0.2, n=74). A true positive was
required to be differentially expressed in the same direction according
to both RNA-seq and qRT-PCR.
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ards. For the GP model, 10 ‘no-call’ genes had a P-value
  the median P-value of the positive standards (i.e. false
positives), and 95 ‘no-call’ genes had a P-value   the
median P-value of the negative standards (i.e. false nega-
tives). However, if we used the Poisson model, the number
increased to 56 for the false positives and 117 for the
false negatives. The number further increased to 58 and
125 for the GLM model. The results were similar if
the QuantiGene data were used as gold standards
(Supplementary Figure S6). Note that for the MAQC-2
data, there were no extremely high gene expression levels
even based on the Poisson model (see Supplementary
Figure S7). But we still observed a signiﬁcant improve-
ment of the GP model over other methods. Thus, the
advantages of the GP model are not limited to the nor-
malization issue.
We applied the GP model to the human tissue data and
identiﬁed the tissue-speciﬁc genes. Speciﬁcally, for each
tissue, we counted the number of genes differentially ex-
pressed between this tissue and all the other eight tissues.
The differentially expressed genes were determined with
FDR threshold 0.0001. Figure 4 shows that the GP
model identiﬁed much fewer tissue-speciﬁc genes than
the Poisson model. The brain tissue had the largest
number of tissue-speciﬁc genes followed by liver and
muscle (grey bars). However, if we used the Poisson
model, liver had much more tissue-speciﬁc genes than
brain (2301 versus 1871). Based on the GP model,
we identiﬁed 119 housekeeping genes with constant
expression levels across the nine different tissues (thus,
not differentially expressed between any two tissues).
Enriched gene annotations included ‘ribonucleoprotein
complex’, ‘ribosome biogenesis’, ‘rRNA processing’,
‘RNA processing’ and so on. These were analyzed by
the David gene annotation tool (18). The number of
housekeeping genes dropped to 19 if the Poisson model
was speciﬁed. The pattern was similar if we used the
simulation strategy to calculate the P-values
(Supplementary Figure S8).
Identiﬁcation of differentially spliced exons
Based on the GP model, we can also identify differentially
spliced exons using the log-likelihood ratio tests. We
focused on the middle exons and compared the splicing
ratio of  e/ g between two samples. Figure 5A plots the
number of differentially spliced exons for each pair of
human tissues. It clearly shows that brain was the tissue
that had the greatest number of the differentially spliced
exons, which was consistent with previous reports using
microarrays (19) or EST-based approaches (20). However,
if we assumed a Poisson model, many other tissues had a
larger number of differentially spliced exons (Figure 5B).
We used a more stringent FDR criterion for the Poisson
model to make the total number of discoveries approxi-
mately equal to that of the GP model. Still, the pattern
was different from that of the GP model (Figure 5C). Note
that Pan et al. (21) used the similar way to present their
results by plotting the boxes. In our data preprocessing,
we mapped the reads that cannot be mapped to the
genome to the refseq RNA sequences, and treated them
as junction reads. Both junction reads and body reads
were used for the GP model. Here, we remapped the
reads to an enlarged junction list from ref. (5) to get a
more complete junction read counts. Then we calculated
the inclusion rate of a middle exon as: the number of
inclusive junction reads/(the number of inclusive
junction reads + the number of exclusive junction
reads). The absolute differences of the inclusion rates
between each pair of tissues were calculated and
compared between the differentially spliced exons
identiﬁed by the GP model and those identiﬁed by the
Poisson model (Figure 5D). Apparently, the differentially
spliced exons identiﬁed by the GP model had a larger
inclusion rate difference between the two compared
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Figure 4. Number of tissue-speciﬁc genes. For each human tissue, we counted the number of genes differentially expressed between this tissue and all
the other eight tissues. Grey bars are for the GP model and the white bars are for the Poisson model. The shaded regions represent the shared genes
between the GP and Poisson models. Only genes with existing MLEs of the parameters for both the GP and the Poisson models in the two compared
samples were considered.
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they also had a larger inclusion rate difference than those
identiﬁed only by the Poisson model. The results indicated
that the GP-based approach can better identify differen-
tially spliced exons. The pattern was similar if we used
the simulation strategy to calculate the P-values
(Supplementary Figure S9).
Comparison with other models
The negative binomial distribution has been used to model
the additional variation from biological replicates for the
digital gene expression (DGE) data (22). In the review
article (23), the authors also mentioned that the back-
ground tag distribution for the chip-seq data can be
Ly Te Ad Co Mu He Li Bre Bra
Ly Te Ad Co Mu He Li Bre Bra
Ly
Te
Ad
Co
Mu
He
Li
Bre
Bra
Ly Te Ad Co Mu He Li Bre Bra
Ly
Te
Ad
Co
Mu
He
Li
Bre
Bra
Ly
Te
Ad
Co
Mu
He
Li
Bre
Bra
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Figure 5. Identiﬁcation of differentially spliced exons. (A–C) The number of differentially spliced exons for each pair of human tissues. Only middle
exons with existing MLEs of the parameters for both the GP and the Poisson models in each pair of tissues were considered. (A) is for the GP model
with FDR 0.01 for each two-tissue comparison, (B) is for the Poisson model with FDR 0.01, (C) is for the Poisson model with FDR 1.0 10
 14. The
size of each black box indicates the number of differentially spliced exons. However the size of the boxes between different panels (A–C) is not
comparable. The total discoveries for (A–C) are: 5099, 94849 and 5719. Ly, lymph node; Te, testes; Ad, adipose; Co, colon; Mu, muscle; He, heart;
Li, liver; Bre, breast; Bra, brain. (D) The difference of the inclusion rates calculated from the junction reads for the differentially spliced exons
identiﬁed by the GP model (GP) or the Poisson model (P). The differentially spliced exons speciﬁc to the GP (GP_speciﬁc) or the Poisson (P_speciﬁc)
models are also shown. The FDR was controlled at 0.01.
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study, the ROC in Figure 3 shows that the negative
binomial performs even worse than the Poisson model.
Actually we found that the variance of the gene-level
read count was not always larger than the mean across
replicates. For example, for the MAQC-2 UHR sample,
considering the gene-level read counts across seven repli-
cate lanes, 37% of the genes had a smaller sample variance
than the sample mean and 60% of the genes had a larger
sample variance than the sample mean. For the MAQC-2
brain sample, 32% of the genes had a smaller sample
variance than the sample mean and 64% of the genes
had a larger variance. These indicate that for the gene-
level read counts, there is both overdispersion and
underdispersion. The negative binomial which can only
handle overdispersion is inappropriate to handle the
gene-level read counts. If we ﬁtted the negative binomial
distribution to the position-level read counts, the
goodness-of-ﬁt was much better than that for the
Poisson model. But it was still worse than the GP model
(Supplementary Table S2). The estimated mean from the
negative binomial model was treated as the gene expres-
sion estimate. The QuantiGene data were used as gold
standards to test the performance again. The slope for
the linear regression between the ‘true’ signal and the
estimate on the log scale was 0.72 (R
2=0.62) and 0.63
(R
2=0.49) for the two MAQC-2 samples. They were dif-
ferent from 1.0 and worse than the GP model. In terms of
computational efﬁciency, although the calculation of
MLEs for both the GP model and the negative binomial
model utilized a numerical optimization method, the latter
was slower because of the involvement of the Gamma
function. For example, it took the GP model  1min to
estimate the expression levels for the MAQC data, but it
took the negative binomial model  12min. All the results
indicate that the GP model was better than the negative
binomial model.
Recently, Li et al. (24) used the properties of local se-
quences to model the varying Poisson rates for different
positions and provided an R package ‘mseq’. The Poisson
rate of each position was modeled as dependent on
the gene expression level and the nucleotide sequence
surrounding this nucleotide. To compare the GP model
with the mseq model, we simulated a bootstrap sample
for the position-level read counts based on the ﬁtted GP
distribution or the ﬁtted Poisson rates from the mseq
model. Then the Kolgomorov–Smirnov test was per-
formed to compare the bootstrap sample from the ﬁtted
model and the observed sample. Ideally the two samples
should have similar distributions. For the GP model,
 50–98% genes with a P-value >0.05, which indicates
that the bootstrap sample approximated to the observed
sample. However, the percentage was only  0–2.04% for
the mseq model. Details can be found in Supplementary
Table S3. The QuantiGene data were used as gold stand-
ards to test the expression estimates of the mseq model.
The slope for the regression lines was 0.61 (R
2=0.62) and
0.58 (R
2=0.54). It indicates that the expression estimates
from the mseq model were worse than those from the GP
model. We should also note that the mseq model provides
a read count estimate for each position, but the GP model
only provides the overall gene expression estimate without
specifying the expression level of each position.
DISCUSSION
In this work, we focused on the position-level read count
(i.e. the number of reads starting from each position).
We found that a two-parameter GP model can ﬁt the
position-level read counts more appropriately than a trad-
itional Poisson model. The parameter   reﬂects the tran-
script amount for a gene (or an exon) and the parameter l
represents the average bias during the sample preparation
and sequencing process for this gene (or exon). The
goodness-of-ﬁt studies showed that the GP model ﬁts
the position-level read count much better than the
Poisson model. Through the GP model, we can better
estimate gene and exon expression levels and perform
the normalization across different samples. The GP
model improves the identiﬁcation of differentially ex-
pressed genes and the identiﬁcation of differentially
spliced exons.
The estimated gene expression ^   can be treated as a
shrunk value of the sample mean, because ^   ¼   x 1   ^ l
  
and ^ l is a positive value (but <1) for more than 99% of
the exons and genes in our applications. In this sense, ^ l
can be treated as a shrinkage factor for the gene expres-
sion estimation. This relationship can also be inferred by
the equation that  = (1 l). Because ^ l had a positive
correlation with
ﬃﬃﬃ
  x
p
, we shrunk more for the highly ex-
pressed genes or we removed more reads due to
sequencing bias. In contrast to microarray data in which
the signal is saturated at a certain threshold, RNA-seq
data have some extremely large values. However, when
we examined the details of the highly expressed genes,
we found some suspicious large number of reads starting
from several positions of the genes. These outliers substan-
tially affected the sample mean estimation (Figure 2).
On the contrary, our GP model can remove these suspi-
cious reads and obtain a more reasonable expression
estimate. From our real data analysis, we also found a
positive correlation between ^ l and the sample standard
deviation s. In addition, ^ l also had high correlations
with certain A/T enriched oligonucleotides for the
commonly used library preparation procedures such as
random hexamer priming or oligo(dT) priming in
human and yeast. However, if the RNA hydrolysis was
used before cDNA priming such as in the mouse data, the
associated oligonucleotides were changed. More RNA-seq
data are needed to draw a conclusion here. Further inves-
tigation is needed to study the underlying mechanisms of
l. Hansen et al. (25) found that the random hexamer
priming induces bias in the nucleotide composition at
the beginning of the sequence reads and they proposed a
reweighting scheme for the read count. We can easily in-
corporate it into our data preprocessing to further remove
such bias.
The shrinkage property of the GP model has an imme-
diate impact on the normalization across different
samples, because a few highly expressed genes speciﬁc to
one sample makes the library-size based normalization
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top 10 genes contributed  31% of the total RNA amount
if the   x was used to estimate the gene expression. If these
10 genes are not expressed in the second tissue and we
assume that the total RNA amounts are equal for the
normalization, the RNA amounts of the remaining
genes are actually very different between the two tissues.
Let’s insert hypothetical values for this example. The
RNA amount from the 10 genes in the liver tissue is
31 and the RNA amount from the remaining thousands
of genes is 69. If the 10 genes are not expressed in the
second tissue (i.e. 0 RNA amount), the RNA amount
for the remaining genes will be scaled to 100 to make
the total RNA amount equal. However, the identiﬁcation
of differentially expressed genes among the remaining
genes will be problematic because their total RNA
amount is 69 versus 100. On the contrary, in our GP
model, the contribution from the top 10 genes was
shrunk to 1–4% for all of the considered tissues. It there-
fore improves the identiﬁcation of differentially expressed
genes and the identiﬁcation of differentially spliced exons
(see Table 4, Figures 4 and 5). In the future, we can
improve the normalization by further removing extreme
values from the GP model and adding the weights about
the robustness of the estimates, similar to the method
proposed in ref. (7).
To evaluate the performance of the GP model on the
identiﬁcation of differentially expressed genes, we used
technical or biological replicates as negative controls.
For the technical replicates, ideally, there should be
no differentially expressed genes. We found that if the
sequencing depth was comparable, the GP model
identiﬁed no false positives in general. But the Poisson
model identiﬁed many false positives. As we expected,
the difference between biological replicates was larger
than the difference between technical replicates. For the
very unbalanced design (i.e. the sequencing depth was very
different between the two samples), the GP model still
performed better than the Poisson model. If the
sequencing depth was the same, the performance of the
GP model was much better than that of the Poisson
model. The results also demonstrate that the advantages
of the GP model over the Poisson model are not limited to
the normalization issue. The ROC curve studies also
concluded that the GP model can better identify differen-
tially expressed genes (Figure 3).
If the sequencing depth is very different for the two
samples, besides the difﬁculty of normalization, the differ-
ent robustness of the parameter estimation is another
issue. As reported in ref. (3), the RPKM estimation was
sensitive to the total number of mapping reads for genes
with low expression levels. We also showed that the par-
ameter estimation for the GP model was sensitive to the
sequencing depth for genes with low expression levels
(Supplementary Figure S2). Therefore, we suggest design-
ing a comparable sequencing depth to perform sample
comparison. In addition, a deeper sequencing depth will
provide us more stable expression estimates. The deeper
sequencing yields more sequence reads. A longer read can
help to map to the genome more accurately. However it
does not contain any addition information about the
sampling property of the RNA-seq data.
We used the maximum likelihood approach to estimate
the parameters in the GP model. If a gene expression level
is too low and there is no position with more than one
read, the MLE does not exist. For the identiﬁcation of
differentially expressed genes and differentially spliced
exons, we used the log-likelihood ratio tests. Under
the null hypothesis, we calculated the proﬁle likelihood.
Our parameter of interest is  = 1/ 2 (or  =( Z/ X)/
( V/ Y)=b1/b2 for differentially spliced exons study) and
under the null  =1. There are nuisance parameters  , b
and ls. For the ﬁrst two parameters, we estimated them in
a usual way. However, we found that ls are very depend-
ent on   and they cannot be treated as orthogonal par-
ameters (results not shown). For simplicity, we treated the
l estimates from the unrestricted model as true values and
put them into the proﬁle likelihood calculation. A more
sophisticated method can be speciﬁed to better calculate
the proﬁle likelihood, but it will increase the computation-
al complexity. Here we also provided a simulation strategy
to estimate the null distribution of the test statistics
instead of using the chi-square distribution with one
degree of freedom.
In the GP model, we made an implicit assumption that
the observed position level counts are independent for dif-
ferent positions of a gene. If the dependence of different
positions is high, the error rate for the expression estimate
will be high ( 10-fold increase for correlation around
0.5 compared with the independent case). Details about
the simulation study can be found in Supplementary Table
S4. However, in the real situation, the positions close to
each other may be dependent on each other, but the pos-
itions far away should be independent. Thus, there is a
block-wise correlation structure. The error rate should
be smaller than the case where all of the positions are
dependent on each other with a correlation 0.5. More
sophisticated model can be developed to better address
the dependence issue in the future.
The current studies of alternative splicing using
RNA-seq data focus on the junction reads and calculate
the ‘inclusion rate’. The ‘inclusion rate’ was represented by
the ratio between inclusive junction reads and the sum of
inclusive and exclusive junction reads. In exon array
studies, the differentially spliced exons were examined in
terms of the comparison between the ‘splicing ratios’, and
the ‘splicing ratio’ was represented by the ratio between
exon expression and gene expression. The ‘inclusion rate’
is always  1, but the ‘splicing ratio’ can be >1 because the
‘gene expression’ is an overall estimate of the expression
levels of multiple isoforms. Therefore, the value of the
‘splicing ratio’ in a single sample alone cannot give us
much information, but the comparison of the two
‘splicing ratios’ is meaningful to identify differentially
spliced exons. On the contrary, the ‘inclusion rate’ in a
single sample contains the information about whether
this exon is alternatively spliced. However, the sequencing
depth is usually too low to obtain enough junction reads
and the positional bias is strong. In this work, we showed
that the GP model can better identify differentially spliced
exons using the ‘splicing ratio’ approach. More
e170 Nucleic Acids Research, 2010,Vol.38, No. 17 PAGE 14 OF 15importantly, the fold change of two different genes of the
same sample can be accurately estimated by the GP
model. Therefore, in the future, we will compare an
exon with a constitutive exon in the same sample to
identify alternatively spliced exons based on the GP
model.
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